COVID-19 infection caused by SARS-CoV-2 is considered catastrophic because it affects
multiple organs, particularly those of the respiratory tract. Although the consequences of this …

Recently, several studies have highlighted a skewed prevalence of infectious diseases
within the African continent. Furthermore, a growing number of studies have demonstrated …

Simple Summary Cancer patients are considered a high-risk group for infectious diseases
including COVID-19. The protective effects of vaccination are unclear in oncologic patients …

The corona virus disease 2019 (COVID-19) global pandemic has had an unprecedented
and persistent impact on oncological practice, especially for patients with lung cancer, who …

Introduction SARS-CoV-2 infection increases the risk of worse outcomes in cancer patients,
including those with breast cancer. Our previous study reported that the SARS-CoV-2 …

The goal of cancer research is to identify characteristics of cancer cells that allow them to be
selectively eliminated without harming the host. One such characteristic is autophagy …

Recent research efforts have shown that tea has activities against SARS-CoV-2. However,
the active compounds and the action mechanisms are largely unknown. Here we study the …

Abstract Angiotensin-converting Enzyme 2 (ACE2) collaborates with Angiotensin (Ang) 1-7
and Mas receptors to establish the ACE2-Ang (1-7)-Mas receptor axis. ACE2 impacts lung …

Background Bladder cancer (BLCA) is a prevalent urinary system malignancy.
Understanding the interplay of immunological and metabolic genes in BLCA is crucial for …

It is unclear whether patients with cancer present inherently impaired responses to COVID-
19 and vaccination due to their treatments, neoplastic diseases or both. To address this …